
1. Technology overview
Epistra Inc. is a Tokyo-based company (Shinagawa-ku), established in March 2018, that applies AI and laboratory robotics to life science research and development. It targets the slow, manual experiment cycles in cell culture and regenerative medicine.
Epistra Accelerate is its AI-driven solution that automates experiments and uses the resulting data to optimize them: it proposes the next experimental conditions and visualizes response surfaces. The company also offers AI custom culture media development and manufacturing and system development services. Named case studies include Astellas Pharma, Shimadzu, Spiber and VisionCare.
2. Highlighted features & specifications
- Experiment optimization: suggests next experimental conditions from accumulated data.
- Response surface view: visualizes how conditions affect results.
- Lab automation: combines AI with robotics to run experiments.
- Custom culture media: AI-designed media development and manufacturing with stable supply.
- System development: planning, design, development and operation tailored to clients.
- Case support: documented use cases with pharma, instrument makers and biotech.
3. Potential application
A cell therapy developer optimizing culture media recipes. A biopharma lab automating condition screening for protein expression. An instrument maker co-developing AI-assisted experiment workflows for its devices.
4. Benefits
Reduces the number of trials needed to reach an optimal condition by suggesting the next experiment automatically. The site cites a case where structural protein R&D was cut from about two years to weeks (Spiber, vendor-reported). Combines AI, robotics and data utilization in one offering for life science R&D.
5. Market trends & opportunities
Life science R&D is shifting toward closed-loop experimentation in which AI proposes conditions and robots execute them. Cell culture media and regenerative medicine processes are costly to optimize by hand. Vietnamese biotech, vaccine and cell therapy start-ups could use such tools as lab automation spreads in Southeast Asia.
6. Other information
Epistra Inc., Shinagawa-ku, Tokyo, established March 2018. The AI custom culture media service was launched with Shimadzu and Shimadzu Diagnostics in February 2026. The company participates in a JST project on unmanned research facilities.
One platform connecting startups, corporations, research institutions, regions and investors











Playbook & Handbook · February 6, 2026
Winning Accelerator Playbook 2026 by BambuUP
RETAIL E-COMMERCE: AI AND REAL-TIME DATA ARE TRANSFORMING HOW RETAIL BUSINESSES OPERATE








































